UPLC-Q-TOF/MS-Based Serum Metabolomics Reveals the Anti-Ischemic Stroke Mechanism of Nuciferine in MCAO Rats

MLA

Lanlan Wu, et al. “UPLC-Q-TOF/MS-Based Serum Metabolomics Reveals the Anti-Ischemic Stroke Mechanism of Nuciferine in MCAO Rats.” ACS Omega, vol. 5, no. 51, Dec. 2020, pp. 33433–44. EBSCOhost, https://doi.org/10.1021/acsomega.0c05388.

APA

Lanlan Wu, Chang Chen, Yongbiao Li, Cong Guo, Yuqing Fan, Dingrong Yu, Tinglan Zhang, Binyu Wen, Zhiyong Yan, & An Liu. (2020). UPLC-Q-TOF/MS-Based Serum Metabolomics Reveals the Anti-Ischemic Stroke Mechanism of Nuciferine in MCAO Rats. ACS Omega, 5(51), 33433–33444. https://doi.org/10.1021/acsomega.0c05388

Chicago

Lanlan Wu, Chang Chen, Yongbiao Li, Cong Guo, Yuqing Fan, Dingrong Yu, Tinglan Zhang, Binyu Wen, Zhiyong Yan, and An Liu. 2020. “UPLC-Q-TOF/MS-Based Serum Metabolomics Reveals the Anti-Ischemic Stroke Mechanism of Nuciferine in MCAO Rats.” ACS Omega 5 (51): 33433–44. doi:10.1021/acsomega.0c05388.